Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01153581 · ClinicalTrials.gov registry record · Phase 2

Sex Hormones and Orthostatic Tolerance

A Phase 2 study of Orthostatic Intolerance, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
109
Enrollment target
1
Study location

NCT01153581 is a Phase 2 study of Orthostatic Intolerance that has completed, run by Yale University. The registered enrollment target is 109 participants, below the 139-participant average among 5 other Orthostatic Intolerance trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01153581, a Phase 2 study of Orthostatic Intolerance, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

This study is designed to determine the causes of "orthostatic intolerance" which occurs more commonly in women than in men. Orthostatic tolerance is the ability to remain standing up right for long periods of time, or to avoid dizziness when moving to standing from a seated or lying position.

Conditions Studied

Orthostatic Intolerance

Interventions

  • DRUG Progesterone
  • DRUG Ganirelix acetate
  • DRUG 17β-Oestradiol

Study Locations (1)

Connecticut

  • John B. Pierce Laboratory - New Haven

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2006-02
Est. Completion 2013-05
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01153581

The ClinicalTrials.gov registry entry for NCT01153581 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 5 other Orthostatic Intolerance trials with a reported enrollment target (22% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Orthostatic Intolerance appearing as the primary indexed condition, and to 3 interventions - of which Progesterone is the first listed.

NCT01153581 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01153581 about?

NCT01153581 is a clinical study titled "Sex Hormones and Orthostatic Tolerance". This study is designed to determine the causes of "orthostatic intolerance" which occurs more commonly in women than in men. Orthostatic tolerance is the ability to remain standing up right for long periods of time, or to avoid dizziness when moving to standing from a seated or lying position.

What is the current status of trial NCT01153581?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 109 participants. The study started on 2006-02. Estimated completion is 2013-05.

What conditions does trial NCT01153581 study?

This clinical trial studies the following conditions: Orthostatic Intolerance.

What interventions are being tested in trial NCT01153581?

The interventions under investigation include: Progesterone (DRUG), Ganirelix acetate (DRUG), 17β-Oestradiol (DRUG).

Who is sponsoring clinical trial NCT01153581?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01153581 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Orthostatic Intolerance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Orthostatic Intolerance

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.